Skip to content
← Back to this collection

PUBLICATIONS · 22378655

FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2012 Oct
First author
Kutny MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kutny MA
      type
      Author
    2. name
      Moser BK
      type
      Author
    3. name
      Laumann K
      type
      Author
    4. name
      Feusner JH
      type
      Author
    5. name
      Gamis A
      type
      Author
    6. name
      Gregory J
      type
      Author
    7. name
      Larson RA
      type
      Author
    8. name
      Powell BL
      type
      Author
    9. name
      Stock W
      type
      Author
    10. name
      Willman CL
      type
      Author
    11. name
      Woods WG
      type
      Author
    12. name
      Meshinchi S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kutny MA
      type
      Author
    2. name
      Moser BK
      type
      Author
    3. name
      Laumann K
      type
      Author
    4. name
      Feusner JH
      type
      Author
    5. name
      Gamis A
      type
      Author
    6. name
      Gregory J
      type
      Author
    7. name
      Larson RA
      type
      Author
    8. name
      Powell BL
      type
      Author
    9. name
      Stock W
      type
      Author
    10. name
      Willman CL
      type
      Author
    11. name
      Woods WG
      type
      Author
    12. name
      Meshinchi S
      type
      Author
    bibliography ids
    1. nci-bib-8c7c1fabef56cf173e5d6d32
    book metadata
    content sha256
    7aa77ab4d64b02ae0800dde86b663662394f643f2e967a175304ad3240ef711f
    document type
    citation
    dois
    1. 10.1002/pbc.24122
    electronic publication date
    display
    2012 Feb 29
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22378655
    immutable id
    pubmed:22378655@7aa77ab4d64b02ae0800dde86b663662394f643f2e967a175304ad3240ef711f
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    4
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    662-7
    volume
    59
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22378655
      provenance
      batch id
      b6284687e167e7da9556
      provider
      NCBI PubMed ESummary
      record sha256
      450e0b5cdef3ee447ac50026a779883a0796a7b0691542adb23d774667dfed88
      response sha256
      64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
      retrieved at
      2026-09-09T23:46:45.216259+00:00
      publication date
      display
      2012 Oct
      precision
      month
      year
      2012
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22378655/
      title
      FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.

      Preserved source evidence · Independent clinical review pending · Not medical advice